Cheryl A. Kollin, NMD
Cheryl A. Kollin, NMD, is a highly qualified naturopathic physician with a strong background in nutrition, clinical laboratory science, and medical technology. She earned her Doctor of Naturopathy (NMD) degree from the Southwest College of Naturopathic Medicine in Tempe, AZ, where she studied from 2009 to 2012. She also holds a Master of Science in Nutrition from the University of Bridgeport in Bridgeport, CT, which she earned from 2005 to 2007.
Dr. Kollin’s educational journey began with an undergraduate degree in biology from Oral Roberts University in Tulsa, OK, where she also minored in chemistry and Spanish. During this time, she conducted molecular biology research and authored a paper titled “Comparison of the Cofactor Requirements for Iron Reductase Secreted by Listeria monocytogenes and for Iron Reductase Produced by Cloned Listeria DNA.”
Dr. Kollin holds two professional licenses: a Naturopathic Medical License (NMD) from Arizona State and a Clinical Laboratory Scientist (CLS) license from California State. She is also certified by the American Clinical Nutritionist Certification Board.
Dr. Kollin has held a number of positions in the medical field, including Senior Scientist and CLS I/II at Rational Therapeutics, Inc. in Long Beach, CA, from 2001 to 2009, and Director of Research, Online Division at the American Nutrition Association in Chicago, IL, from 2008 to 2010.
She has also been a member of several professional organizations throughout her career, including the American Association of Naturopathic Physicians and the International and American Association of Clinical Nutritionists.
Dr. Kollin has contributed to the scientific community through her research, including a manuscript titled “Comparison of 1st Line Treatment Options In Epithelial Ovarian Cancer: Ex Vivo Analysis in Human Tumor Primary Culture Micro-spheroids” that is currently pending publication.
Overall, Dr. Kollin’s extensive education and professional experience have made her a respected and knowledgeable naturopathic physician, dedicated to improving the health and well-being of her patients.
Cheryl A. Kollin's Extended Bio
Curriculum Vitae
Cheryl A. Kollin, NMD
GRADUATE & POSTGRADUATE EDUCATION
• Southwest College of Naturopathic Medicine, Tempe, AZ (2/09- 12/12)
Doctor of Naturopathy (NMD)
• University of Bridgeport, Bridgeport, CT (9/05- 5/07)
M.S. Nutrition
• California State University Dominquez Hills, Carson, CA (1992-1993)
PROFESSIONAL SCHOOL EDUCATION
• St. Mary Medical Center, School of Medical Technology, Long Beach, CA (1993-
1994)
UNDERGRADUATE EDUCATION
• Oral Roberts University, Tulsa, OK (1988-1992)
B.S. Biology (major), Chemistry and Spanish (minors)
Molecular Biology Research and Paper: Comparison of the Cofactor Requirements
for Iron Reductase Secreted by Listeria monocytogenes and for Iron Reductase
Produced by Cloned Listeria DNA.
LICENSURE
• Naturopathic Medical License, NMD, Arizona State (AZ 13-1361)
• Clinical Laboratory Scientist, CLS, California State License (MTA36232)
CERTIFICATION BOARDS
• Certified Clinical Nutritionist (CCN), #4037 (2007-present)
• MT (ASCP) Certified #193720 (1994-present)
• NCA Certified (1994)
EMPLOYMENT HISTORY
• October 2014 to Present, Naturopathic Medical Doctors of Arizona, Tempe, AZ,
Physician
• April 2013 to October 2014, Naturopathic Medical Doctors of Arizona, Tempe, AZ,
Independent Physician Contractor
• March 2008 to August 2010, American Nutrition Association, Chicago, IL, Director
of Research, Online Division
• September 2001 to January 2009, Rational Therapeutics, Inc., Long Beach, CA,
Senior Scientist, CLS I/II
• January 1993- September 2001, St. Mary Medical Center, Long Beach, CA, Medical
Technologist I/II.
SMALL BUSINESS
• Kollin Medical (2014 to Present)
o Az Oncology Rehab
• Cheryl K Nutrition (2007 to 2008)
PROFESSIONAL MEMBERSHIPS
• Sigma Xi, Scientific Research Society, associate member (1992 to 2006).
• American Society of Clinical Pathology, ASCP, associate member (1994 to present)
• International and American Association of Clinical Nutritionists, IAACN (2007 to
present)
• American Association of Naturopathic Physicians, AANP (2009 to present)
• Arizona Naturopathic Medical Association (AzNMA), (2010 to present)
• American College for the Advancement of Medicine (ACAM), (2012 to present)
PUBLICATIONS
Manuscripts:
• Brewer CA, Evans SS, Kollin CA, Sommers BL, Su YZ, Nagourney RA. Comparison
of 1st Line Treatment Options In Epithelial Ovarian Cancer: Ex Vivo Analysis in
Human Tumor Primary Culture Micro-spheroids. (pending)
Abstracts:
• Nagourney RA, Kollin CA, Sommers B, Su YZ, Francisco F, Evans SS. Bortezomib
combinations in ovarian cancer: Ex vivo analysis of activity and synergy in human
tumor primary culture spheroids. (2158) Amer Assoc for Canc Res, 2006. (abst)
• Nagourney RA, Sommers BL, Evans SS, Kollin C, Su YZ, Evans T, Islas J, Kakkis J,
Tabar L. Casting-type calcification breast cancer: Assessment of response to
cytotoxic insult in human tumor primary culture spheroids. (680) Amer Soc of
Clin Oncol 24, 2005 (abst)
• Kollin C, Su YZ, Evans SS, Nagourney RA. The effects of EGFr modulation by
Cetuximab & Gefitinib in human tumor primary culture microspheroids. (2170)
Amer Assoc of Canc Res 46, 2005 (abst)
• Nagourney RA, Kollin C, Su YZ, Evans SS. Geldanamycin & 17-allylamino-17-
demethoxygeldanamycin alone and in combination with cytotoxic drugs in human
tumor primary cultures. (1713) Amer Assoc of Canc Res 46, 2005 (abst)
• Evans S, Brewer C, Kollin C, Su YZ, Nagourney RA. The role of targeted therapies
in ovarian cancer: Examination of drug activity in human primary culture
spheroids. (5324) Amer Assoc of Canc Res 46, 2005 (abst)
• Nagourney RA, Su, YZ, Horlick D, Chow C, Kollin C, Evans SS. Bortezomib (PS-341)
alone and in combination with cytotoxic drugs: Ex vivo analysis in human tumor
primary cultures. (3690) Amer Assoc of Canc Res 45, 2004 (abst)
• Evans SS, Brewer C, Su YZ, Yeung C, Chow C, Horlick D, Kollin C, Nagourney RA.
Gemcitabine/Antifol combinations in human tumor primary cultures: Potential
role in gynecologic malignancies. (4446) Amer Assoc of Canc Res 45, 2004 (abst)
• Nagourney RA, Chow C, Kollin C, et al. Effect of gefitinib (Iressa, ZD 1839) in
human tumor primary cultures: Possible insights into drug actions. (3801) Amer
Assoc of Canc Res 44, 870, 2003 (abst)
• Kollin CA, Evans SS, Su, Y-Z Su, et al. A direct comparison of paclitaxel and
docetaxel activities in human tumors. (655) Proc Amer Soc Clin Oncol 22, 163,
2003 (abstr)
• Su YZ, Kollin C, Horlick D et al. Activity of ZD1839 (Iressa) alone and combined
with cytotoxic drugs in human tumor primary cultures. (3902) Amer Assoc for
Canc Res. 2002. (abst)
• Su YZ, Spall D, Trail MA, Kollin C et al. BEC, a mixture of solasodine glycosides
reveals cytotoxic activity in human tumor primary culture specimens: Pre-clinical
and early clinical observations. (1070). Proc Amer Assoc Canc Res 43:214, 2002
(abstr)
• Nagourney RA, Su YZ, Chow C, Kollin C et al. Arsenic Trioxide (Trisenox) single
agent and combination activity in human lung, colon, breast, and ovarian primary
cultures. ASCO Vol 21, 2002, #2189.
CONTINUING EDUCATION
• Understanding the Clinical Uses of Blood Gases and Electrolytes. AACC 1994. 15
hours
• Cardiac Markers for Diagnosing and Monitoring Heart Disease. AACC 1995. 15
hours
• Transfusion Medicine. ASCP 1994 & 1995 Check Sample Program. 1996. 12 hours
• Laboratory Identification of Blood Parasites. CACMLE 1997. 15 hours
• Clinical Lab Mycology. CACMLE 1998. 15 hours
• Transfusion Medicine. ASCP 1998 & 1999 Check Sample Program. 1999. 16 hours.
• A Review of Routine Hematology Laboratory Procedures. CACMLE 2000. 15 hours
• Transfusion Medicine. ASCP 1999 & 2000 Check Sample Program 2001. 16 hours
• Harper’s Biochemistry, Section A. Anderson Continuing Education 2002. 12 hours
• Harper’s Biochemistry, Section B. Anderson Continuing Education 2003. 12 hours
• Harper’s Biochemistry, Section C. Anderson Continuing Education 2004. 12 hours
• Understanding & Evaluating Common Laboratory Tests, Section A. Anderson CE
2005. 12 hours
• Clinical Biochemistry. Univ. of Bridgeport, Nutrition program. 2006. 3 units = 45
hours.
• Epidemiology and Statistics. Univ. of Bridgeport, Nutrition program. 2007. 3 units
= 45 hours.
• Managing Men’s & Women’s Health. Metagenics Educational Programs, Presented
by Kristi Hughes, ND. Oct. 2005. 6 hours.
• Understanding The Origins & Applying Advanced Nutritional Strategies For
Autoimmune Disease. Metagenics Educational Programs, Presented by Jeffrey S.
Bland, PhD. Feb. 18, 2006. 6 hours
• Obesity-Related Health Problems: New Understanding & New Solutions.
Metagenics Educational Programs, Presented by Robert Rakowski, DC, CCN. Feb.
19, 2006. 6 hours
• Restoring Patient Health through Functional Endocrinology. Metagenics
Educational Programs, Presented by Robert Rakowski, DC, CCN. 2006. 6 hours
• Managing the Multiple Causes of Chronic Inflammation. Metagenics Educational
Programs, Presented by Jacob Kornberg, MD. Oct 2006. 6 hours
• The Neurobiology of Mood & Cognitive Disorders, Metagenics Educational
Programs, Presented by Jay Lombard, DO. Oct. 2006. 6 hours.
• The Top 20 Nutritional Strategies every Health Provider Needs to Know.
Metagenics Educational Programs, Presented by Robert Rakowski, DC, CCN. Feb.
2007. 6 hours
• The Fatigue Solution. Metagenics Educational Programs, Presented by Kristi
Hughes, ND. June. 2007. 6 hours.
• First Line Therapy Certification. FLT Healthcare Provider. Metagenics Educational
Programs. Presented by Kristi Hughes, ND. Sept. 2007, Long Beach, CA.
• Beyond Metabolic Syndrome—Breakthrough Management of Disorders of Insulin
Associated with Age-Related Disease. Metagenics Educational Programs.
Presented by Jeffrey S. Bland, PhD. February 11, 2007, Los Angeles, CA. 6 hours
• The Emerging Therapeutic Target. Metagenics Educational Programs. Presented
by Jeffrey Bland, PhD.. Feburary 9, 2008, Los Angeles, CA. 6 hours
• PSI Seminars. Basic Seminar. June 25, 2008
• The Role of Clinical Nutrition in Pre and Post Traumatic Care. 2008 IAACN
Scientific Symposium. Sept. 4-7, 2008, Baltimore, MD. 20 hours.
• The Effect of Gastrointestinal Integrity on Total Body Health and Well Being. 2009
IAACN Scientific Symposium. Sept 18-21, 2009, Phoenix, AZ. 20 hours
• Nutrigenomic Therapies for Autoimmune Disease. Metagenics Educational
Programs. Presented by Thomas O’Bryan, DC. October 11, 2009, Phoenix, AZ. 6
hours.
• Linking the Signs, Dr. Stephen Stiteler, Apex Energetics. February 20-21, 2010,
Phoenix, AZ. 14 hours.
• Common Clinical Dilemmas and Misdiagnoses. IAACN 2010 Scientific Symposium,
August 18-21, 2010, Las Vegas, NV. 19 hours.
• Introduction to UNDA Numbers and Biotherapeutic Drainage. Seroyal. Presented
by Susan Godman, ND. June 4, 2011, Tempe, AZ.
• Fundamentals and Clinical Applications of IV Nutrient Therapies. Presented by
Virginia Osborne ND, RN. March 7-10, 2013. Tempe, AZ.
• Southwest Botanical Medicine Conference. April 13-14, 2013. Tempe, AZ.
• Integrative Cancer Medicine Symposium, 3rd Annual. Presented by the Healthy
Medicine Academy. April 26-29, 2013. Scottsdale, AZ.
• Suisse Neural Therapy Level I. April 2014. CME: 5 General, 2 Pharmacy
• Suisse Neural Therapy Level II. May 2014. CME: 5 General, 2 Pharmacy
• A Beginner’s Guide to Telemedicine. AzNMA Webinar. Presented by Christine
Girard ND, July 2014. CME: 1 General
• Oxidative Stress and Cancer. AzNMA Webinar. Presented by Lise Alschuler ND,
August 2014. CME: 1.5 Pharmacy
• Integrative Cancer Medicine Symposium, 4th Annual. Presented by the Healthy
Medicine Academy. November 7-10, 2014. Phoenix, AZ. CME: 24.75 General, 7
Pharmacy
• Evaluation and Management of Recurrent Pregnancy Loss. AzNMA Webinar.
Presented by Jaclyn Chasse ND. November 2014. CME: 1.5 Pharmacy
• Naturopathic Pharmaceutical Symptom Management in Integrative Oncology.
AzNMA Membership Meeting. Presented by Shauna Birdsall ND, Adam Keriesvsky
ND, Leah Sherman ND. December 2014. CME: 1 General, 1 Pharmacy
Learn more about our Care Team.